Status:

WITHDRAWN

Improving Sensitivity of Urine Cytology for Bladder Cancer

Lead Sponsor:

Johns Hopkins University

Conditions:

Bladder Cancer

Eligibility:

MALE

18-80 years

Phase:

NA

Brief Summary

Can a commercially available vibrating chair increase the number of urothelial cells in a urine sample of healthy participants non-invasively? The investigators plan is participants will alternate 15 ...

Eligibility Criteria

Inclusion

  • Only adult male subjects who will not have surgery within a period of 2 weeks.
  • Over the age of 18
  • Have had a confirmed diagnosis of stage 0-4 transitional cell carcinoma within the last 30 days

Exclusion

  • Cognitive impairment resulting in the inability to give informed consent
  • Lack of spoken and written English resulting in the inability to give informed consent
  • Presence of infectious disease
  • Insulin dependent diabetes mellitus
  • Endogenous osteosynthetical material implants
  • Knee or hip prosthesis
  • Pacemaker
  • Epilepsy
  • Musculo-skeletal disorders
  • Weight in excess of 250 pounds
  • Poor circulation

Key Trial Info

Start Date :

January 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2013

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01826097

Start Date

January 1 2013

End Date

November 1 2013

Last Update

February 1 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21287